Compass Therapeutics CMPX
NASDAQ CMPX
$2.42 +0.06 (+2.32%)
As of: Sep 4, 2026 · 1:32 PM EDT

Compass Therapeutics (CMPX) Net Shares Issued and Repurchased (2020 - 2026)

Analysis

Compass Therapeutics (CMPX) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn -
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -
5 Revolution Medicines 44.08 Bn 44.08 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn -
8 Royalty Pharma 28.44 Bn 27.60 Bn - -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -
10 Compass Therapeutics 452.99 Mn 452.99 Mn - 2.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Mn
Mar 31, 2026 9.31 Mn
Dec 31, 2025 4.78 Mn
Mar 31, 2025 4.48 Mn
Dec 31, 2024 6.19 Mn
Mar 31, 2024 3.44 Mn
Dec 31, 2023 2.80 Mn
Dec 31, 2022 2.28 Mn
Mar 31, 2022 1.96 Mn
Dec 31, 2021 1.82 Mn
Mar 31, 2021 1.10 Mn
Dec 31, 2020 2.18 Mn
Sep 30, 2020 1.63 Mn
Jun 30, 2020 634,491.00